Overview

Gender

male

Investor Type

Investment Partner

Harry Rein is Partner Emeritus at Foundation Medical Partners.

Mr. Rein served for 15 years as the Founder and Managing General Partner of Canaan Partners. In addition to his role as the managing general partner at Canaan Partners, Mr. Rein was responsible for Canaan's Life Sciences Investment Practice.

Prior to Canaan Partners, for four years he was President and CEO of GE Venture Capital Corporation. Mr.Rein has extensive experience with small and mid-sized companies, including the supervision of all investments made by GE Venture Capital during his tenure as president. Mr. Rein joined the General Electric Company ("GE") in 1979 and directed several of GE's lighting businesses as general manager before joining the venture capital subsidiary.

He has also worked for Transaction Systems, Inc., a strategic consulting firm, as a Vice President; with Gulf Oil Corporation as Director of Corporate Planning; and with Polaroid Corporation in several manufacturing positions.

Mr. Rein has served on the Boards of directors of over 20 public and private entrepreneurial companies, including: Cell Pathways, OraPharma (acquired by Johnson & Johnson), National MD (acquired by GE), OmniSonics, GenVec (NASDAQ: GNVC), CardioNet (NASDAQ: BEAT) and Spine Wave, and was an investor in Praecis Pharmaceuticals (NASDAQ: PRCS).

Currently, Mr. Rein serves on the Board of Directors of Anadigics (NASDAQ: ANAD), and Marinus Pharmaceuticals.

Previously, Mr. Rein was a member of the Board of Directors of the National Venture Capital Association ("NVCA") and was the recipient of the 2002 NVCA Outstanding Service Award. Mr. Rein also serves as a Trustee of the Cleveland Clinic and is a member of the Clinic's Research and Education, and Finance committees. Mr. Rein is Chairman of the Innovations Advisory Board of Cleveland Clinic. He also serves as a Trustee of the University of Virginia Darden School of Business Foundation, where he is a member of the Executive Committee and Chairman of the Investment Committee.

Mr. Rein attended Emory University and Oglethorpe College (1968) and hold an M.B.A. from the Darden School at the University of Virginia (1973).